http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6743899-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de31db2ffbcf8b9e531f60a7fa5a2cc1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-14
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-775
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-14
filingDate 2001-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2004-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43fce66eab1fa9897d2fd3bddd5bca4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2564e554a73b6fde51f933bde1064236
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5c7cb518a235d49ef20f57ec1631e2c
publicationDate 2004-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6743899-B2
titleOfInvention Process for inactivating prions in lipoproteins
abstract A process for treatment of a purified lipoprotein material to inactivate prions in a manner that does not substantially adversely affect the biological activity of the lipoprotein is provided that includes treating the lipoprotein prion composition with a solution of base at a pH of between 10 and 13 for a sufficient time to cause inactivation.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009118470-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004167071-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8293174-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005054003-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007023178-A1
priorityDate 2001-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4762792-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5756678-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0742018-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5633349-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0937735-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4290774-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127688846
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129121548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6331297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121089
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127612962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11025495

Total number of triples: 45.